Chiome Bioscience Inc. Stock: price and insider trades · Japan

株式会社カイオム・バイオサイエンス

JP·Mcap JP¥4.9B

Chiome Bioscience Inc.: what insiders have been doing

Insider filings for Chiome Bioscience Inc. are scarce in the EDINET (Japan FSA) feed, the latest one published on 5 April 2024. This page will fill in as new trades are disclosed. This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.

Insider Decl.

Thresholds

n/a

Buy Volume

n/a

Sell Volume

n/a

Fundamental score

Ranked 19,828 of 23,476 companies

27.3

score / 100

Value

Quality

FCF yld-20%

Earn yld-20%

EV/EBITDA·

ROE-32%

Gross mgn60%

Net mgn·

Debt/EBITDA·

Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

JP¥68

Analyst consensus

Income statement

RevenueJP¥593.3M

Gross profitJP¥355.6M60% margin

EBITDA-JP¥972.6M-164% margin

Net income-JP¥982.8M-165.6% margin

Valuation

P/Book3.8x

Beta1.87

Balance sheet & cash

Market capJP¥4.9B

Total debtJP¥261.7M

Free Cash Flow-JP¥976.1M

Debt / Equity7%

Profitability & ownership

ROE-31.6%

ROA-19.0%

% insiders10.8%

% institutions0.2%

Last declaration on 5 April 2024

Declarations1 total

●

Barclays Bank PLC

Related company / holdingExecutives29 Mar 2024

0EDINET ↗

ShareXTKSEDINET:S100T7RN

1 of 1 declaration

About Chiome Bioscience Inc.

Kaiohm Bioscience is a Japanese company specializing in biotechnology. It is listed on the XTKS market.

Chiome Bioscience Inc. Stock: price and insider trades · Japan

Chiome Bioscience Inc.: what insiders have been doing

Financial data

About Chiome Bioscience Inc.

Related executives

Chiome Bioscience Inc. Stock: price and insider trades · Japan

Chiome Bioscience Inc.: what insiders have been doing

Financial data

About Chiome Bioscience Inc.

Related executives